Eris Biotech
Our drugs engage the immune system to fight tumors
Lehi, United States · Founded 2023 · $500K raised
- Headquarters
- Lehi, Utah
- Employees
- 1–10
- Founded
- 2023
- Website
- erisbio.com
- Total Funding
- $500K
- Last Round
- $500K SeedMar 2024
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
We are developing cancer therapeutics using small molecules that inhibit immune suppression. Our drugs engage the immune system to aggressively fight tumors. Our therapeutic portfolio addresses a range of solid tumors, starting with mesothelioma.
Summary
Eris Biotech is a Biotech company based in Lehi, United States, founded in 2023. It has raised $500K in total across 1 round, most recently a $500K Seed round in Mar 2024.
Funding History
Mar 2024
Similar Companies
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...
Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/eris-biotech"><img src="https://indexed.vc/api/badge/company/eris-biotech" alt="Eris Biotech on Indexed.vc" width="260" height="76" /></a>